Viscoelastic assays such as TEG â and ROTEM â are increasingly used to guide transfusion of blood products. The EXTEM assay maximum clot firmness (MCF) is a ROTEM measure available after 25-29 min used to guide early decisions. EXTEM A10, the clot firmness at 10 min, is an accepted early surrogate, but investigators differ on whether A5, the clot firmness at 5 min, is acceptable. We re-examined this in a retrospective observational analysis of 1146 trauma patients in one centre who had ROTEM data recorded. A5 and A10 both correlated well with maximum clot firmness, with Pearson coefficients of r = 0.92 and r = 0.96, respectively. The correlations of A5, A10 and maximum clot firmness with requirement for massive transfusion were all similarly high, with c-stats of 0.87, 0.89 and 0.90, respectively. The correlations with mortality were also similar but weaker, with c-stats of 0.67, 0.69 and 0.69, respectively. Using a previously validated cut-off of A5 < 35 mm to predict massive transfusion gave a sensitivity of 95%, specificity 83%, positive predictive value 9.3% and negative predictive value 100%. Using a value of A5 < 29 mm, for a pragmatic positive predictive value of 20%, gave a sensitivity of 67%, specificity 95% and negative predictive value 99%. Whether aiming for a high sensitivity or a strong predictive value, A5 was non-inferior to A10 and actually missed fewer cases needing massive transfusion. A5 has similar utility to both A10 and maximum clot firmness as an early measure of clot firmness, and a low A5 value is strongly predictive of the need for massive transfusion.
Introduction
In the past 15 years, point-of-care viscoelastic testing of blood coagulation, such as thromboelastography (TEG â , Haemonetics Corp, Braintree, MA, USA) and rotational thromboelastometry (ROTEM â , Tem International GmbH, Munich, Germany), has played an increasingly prominent role in the diagnosis and management of the acute coagulopathy of trauma and traumatic bleeding [1] . In particular, it has been used before laboratory tests were available to guide early decisions on blood product transfusion [2] , including triggering a massive transfusion protocol [3] . The functional nature of the tests allows rapid detection of coagulation defects [4, 5] , as well as early differentiation of treatable pathologies such as clotting factor deficiency, platelet depletion or dysfunction, and fibrinolysis [6, 7] . This has been recognised in the Association of
Anaesthetists of Great Britain and Ireland (AAGBI) guidelines on the use of blood components [8] .
A reduced maximum clot firmness (MCF) has been used as a trigger for administration of blood products [9] , but it can take up to 25-29 min to obtain this measurement [10] . For this reason, some researchers in trauma [10, 11] and in peri-operative medicine [12] [13] [14] have investigated whether clot firmness at 5 min (A5) or 10 min (A10) are acceptable substitutes. Meyer et al.
found A10, but not A5, to correlate better with laboratory tests than MCF [10] , and they suggested that early clot amplitude measurements may in fact 'reflect a more dynamic part of the haemostatic process' than MCF.
Using an equivalent but larger database of consecutive trauma patients from a regional trauma centre who had ROTEM measurements, we performed a similar analysis on the utility of A5 and A10. Our thesis was that (1) the first available clot firmness measure A5 would correlate with MCF in a similar fashion to A10 and (2) [15, 16] .
We focused on A5, A10 and MCF using the EXTEM assay [10] [11] [12] [13] . We used scatter plots and Spearman correlation coefficients to examine the relationship of A5
and A10 with MCF. We also compared the correlation between these measures and transfusion requirements and mortality using receiver operating characteristic curves and c-stat values.
The study ended when the loan of the ROTEM machines finished. There was no formal power calculation to determine sample size. We used SAS 9.3 (SAS Institute, Cary, NC, USA) for statistical analysis and significance calculations.
Results Table 1 shows the characteristics of patients enrolled in the study. Major trauma, defined as ISS ≥ 15, was recorded in 635 (55%) of the patients. 
Discussion
The strong correlation of both A5 and A10 with MCF indicate that either of these early clotting measures is acceptable as an early substitute in decision making.
However, A5 and A10 need not be seen only as A5 is a useful early measure of clot firmness, and with appropriate selection of the cut-off value, can be strongly predictive of requirement for massive transfusion.
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